Nabih Habib
Nabih Habib has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ariel Borkowski
Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri
42 shared publications - Bo Peng
Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri
42 shared publications - Brian Andrew Van Tine
Washington University in St. Louis
42 shared publications - Daniel L. J. Thorek
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
42 shared publications - Kavita Rawat
Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, USA
42 shared publications - Kevin Kim
Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri
42 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S10 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
Correlation plots between PSA and sip-T subsets
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S10 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
Correlation plots between PSA and sip-T subsets
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
IL-15 treatment of sip-T significantly improves their cytotoxicity (determined by incucyte) against prostate tumors
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
IL-15 treatment of sip-T significantly improves their cytotoxicity (determined by incucyte) against prostate tumors
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
CyTOF analysis of various immune checkpoint molecules in sip-T subsets
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
CyTOF analysis of various immune checkpoint molecules in sip-T subsets
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
IL-15 expands antigen-specific T-cell subsets of sip-T
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
IL-15 expands antigen-specific T-cell subsets of sip-T
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
IL-15 significantly improves sip-T mediated suppression of tumor growth in vivo
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
IL-15 significantly improves sip-T mediated suppression of tumor growth in vivo
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
IL-15 significantly improves activation of sip-T in peripheral blood in vivo
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
IL-15 significantly improves activation of sip-T in peripheral blood in vivo
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S12 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
Correlation plots between clinical outcomes and sip-T subsets
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S12 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
Correlation plots between clinical outcomes and sip-T subsets
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
Correlation plots between overall survival and sip-T subsets
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from High-Dimensional Analyses Reveal IL15 Enhances Activation of Sipuleucel-T Lymphocyte Subsets and Reverses Immunoresistance
Correlation plots between overall survival and sip-T subsets